Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Aug 14, 2024

SELL
$2.66 - $3.97 $1,995 - $2,977
-750 Closed
0 $0
Q2 2022

Aug 14, 2024

SELL
$2.42 - $4.05 $17,980 - $30,091
-7,430 Reduced 90.83%
750 $1.99 Million
Q1 2022

Aug 14, 2024

BUY
$3.45 - $5.83 $28,221 - $47,689
8,180 New
8,180 $32.1 Million
Q4 2021

Aug 30, 2024

BUY
$4.89 - $7.59 $3,545 - $5,502
725 Added 7.75%
10,080 $55.5 Million
Q3 2021

Aug 30, 2024

SELL
$5.18 - $7.41 $15,540 - $22,230
-3,000 Reduced 24.28%
9,355 $67.5 Million
Q2 2021

Aug 30, 2024

BUY
$3.94 - $6.75 $48,678 - $83,396
12,355 New
12,355 $81.5 Million
Q1 2021

Aug 30, 2024

BUY
$4.03 - $7.25 $12,896 - $23,200
3,200 Added 34.95%
12,355 $53.7 Million
Q4 2020

Aug 30, 2024

BUY
$2.78 - $4.5 $25,450 - $41,197
9,155 New
9,155 $35 Million

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.